Suppr超能文献

葡萄牙初级卫生保健中勃起功能障碍的误诊与治疗不足

Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care.

作者信息

Morgado Afonso, Moura Maria Leonor, Dinis Paulo, Silva Carlos Martins

机构信息

Serviço de Urologia, Centro Hospitalar São João, Porto, Portugal; Departamento de Biomedicina, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

出版信息

Sex Med. 2019 Jun;7(2):177-183. doi: 10.1016/j.esxm.2019.01.004. Epub 2019 Mar 14.

Abstract

INTRODUCTION

The importance of erectile dysfunction (ED) diagnosis and treatment has been highlighted since the early 2000s. However, nearly 20 years after the first phosphodiesterase 5 inhibitor (PDE5i) was marketed, underdiagnosis and undertreatment of ED in the primary health care setting may still be present.

AIM

To assess the relative frequency of patients who are medically treated for ED before referral to specialized urology care. The secondary objectives were to evaluate possible reasons for non-treatment prior to referral and other signs of undertreatment, namely cardiovascular risk assessment and antihypertensive treatment.

METHODS

200 male patients referred for ED to specialist urology care by general practitioners were screened after consent between January 2016-December 2018. A full standardized medical and sexual history were taken. Previous medical treatment of ED, namely pharmacologic name and dosages, and cardiovascular risk factors were noted.

MAIN OUTCOME MEASURES

Of the 115 included patients, only 33.9% of patients had already taken PDE5i before referral, and none had taken alprostadil by intracavernous route.

RESULTS

The mean patient age was 58.68 ± 10.01 years old. Only 45.2% had been prescribed the highest dose of PD5i. From the remaining untreated patients, only 19.7% had ≥3 cardiovascular risk factors, including 5.6% of patients who also presented moderate-to-severe stable or unstable angina requiring a stress test or cardiology assessment before treatment. Regarding the 54 patients with medical history of arterial hypertension, 43.4% and 30.2% were treated for hypertension with a diuretic and a beta blocker, respectively.

CONCLUSION

More focus on the primary healthcare continuous medical education regarding sexual dysfunction, namely ED, is needed because major undertreatment of ED is still present because low prescription of PD5i before referral is noted. Morgado A, Moura ML, Dinis P, et al. Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care. Sex Med 2019;7:177-183.

摘要

引言

自21世纪初以来,勃起功能障碍(ED)诊断和治疗的重要性就已得到强调。然而,在首个磷酸二酯酶5抑制剂(PDE5i)上市近20年后,初级卫生保健机构中ED的诊断不足和治疗不足情况可能仍然存在。

目的

评估在转诊至专业泌尿外科治疗之前接受药物治疗的ED患者的相对频率。次要目标是评估转诊前未治疗的可能原因以及其他治疗不足的迹象,即心血管风险评估和抗高血压治疗。

方法

2016年1月至2018年12月期间,在获得同意后,对200名由全科医生转诊至专业泌尿外科治疗ED的男性患者进行了筛查。采集了完整的标准化病史和性病史。记录了既往ED的药物治疗情况,即药物名称和剂量,以及心血管危险因素。

主要观察指标

在纳入的115名患者中,只有33.9%的患者在转诊前已经服用过PDE5i,且无人通过海绵体内注射途径使用过前列地尔。

结果

患者的平均年龄为58.68±10.01岁。只有45.2%的患者被开具了最高剂量的PDE5i。在其余未治疗的患者中,只有19.7%有≥3种心血管危险因素,其中5.6%的患者还患有中度至重度稳定或不稳定型心绞痛,在治疗前需要进行负荷试验或心脏科评估。在有动脉高血压病史的54名患者中,分别有43.4%和30.2%的患者使用利尿剂和β受体阻滞剂进行高血压治疗。

结论

需要更加关注初级卫生保健中关于性功能障碍(即ED)的继续医学教育,因为ED的主要治疗不足仍然存在,原因是转诊前PDE5i的处方量较低。莫尔加多A、莫拉ML、迪尼斯P等。葡萄牙初级卫生保健中勃起功能障碍的误诊和治疗不足。性医学2019;7:177 - 183。

相似文献

1
Misdiagnosis And Undertreatment Of Erectile Dysfunction In The Portuguese Primary Health Care.
Sex Med. 2019 Jun;7(2):177-183. doi: 10.1016/j.esxm.2019.01.004. Epub 2019 Mar 14.
2
An Evaluation of a Clinical Care Pathway for the Management of Men With Nonorganic Erectile Dysfunction.
J Sex Med. 2019 Oct;16(10):1541-1546. doi: 10.1016/j.jsxm.2019.07.013. Epub 2019 Aug 20.
3
Systematic Review of Oral Combination Therapy for Erectile Dysfunction When Phosphodiesterase Type 5 Inhibitor Monotherapy Fails.
Sex Med Rev. 2019 Jul;7(3):430-441. doi: 10.1016/j.sxmr.2018.11.007. Epub 2019 Jan 30.
5
Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients.
J Sex Med. 2014 Oct;11(10):2546-53. doi: 10.1111/jsm.12647. Epub 2014 Jul 24.
6
The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction.
J Sex Med. 2018 Oct;15(10):1434-1445. doi: 10.1016/j.jsxm.2018.05.021. Epub 2018 Jul 26.
8
[Sex, erectile dysfunction, and the heart: a growing problem].
Herz. 2003 Jun;28(4):284-90. doi: 10.1007/s00059-003-2478-8.
9
Bibliometric Analysis of Erectile Dysfunction Publications in Urology and Sexual Medicine Journals.
J Sex Med. 2018 Oct;15(10):1426-1433. doi: 10.1016/j.jsxm.2018.08.004. Epub 2018 Sep 12.

引用本文的文献

2
Quality and benefits of the erectile dysfunction information on websites, social-media, and applications.
Int J Impot Res. 2024 Nov;36(7):688-692. doi: 10.1038/s41443-023-00725-1. Epub 2023 Jun 27.
4
Can we rely on total testosterone measurement to exclude hypogonadism in erectile dysfunction?
Int J Impot Res. 2023 Aug;35(5):454-459. doi: 10.1038/s41443-022-00565-5. Epub 2022 Mar 28.
5
Spanish Cross-Cultural Validation of the Electronic Version of the International Index of Erectile Function-5 (IIEF-5).
Int J Environ Res Public Health. 2022 Mar 7;19(5):3115. doi: 10.3390/ijerph19053115.
6
General practitioners' self-reported competence in the management of sexual health issues - a web-based questionnaire study from Finland.
Scand J Prim Health Care. 2021 Sep;39(3):279-287. doi: 10.1080/02813432.2021.1934983. Epub 2021 Jul 13.

本文引用的文献

1
The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction.
J Sex Med. 2018 Oct;15(10):1434-1445. doi: 10.1016/j.jsxm.2018.05.021. Epub 2018 Jul 26.
2
Erectile dysfunction and risk of cardiovascular and all-cause mortality in the general population: a meta-analysis of cohort studies.
World J Urol. 2018 Oct;36(10):1681-1689. doi: 10.1007/s00345-018-2318-3. Epub 2018 May 3.
3
Health-Related Lifestyle Factors and Sexual Dysfunction: A Meta-Analysis of Population-Based Research.
J Sex Med. 2018 Apr;15(4):458-475. doi: 10.1016/j.jsxm.2018.02.008. Epub 2018 Mar 6.
4
Do patients consult their GP for sexual concerns? A cross sectional explorative study.
Scand J Prim Health Care. 2017 Dec;35(4):373-378. doi: 10.1080/02813432.2017.1398934. Epub 2017 Nov 6.
5
Evaluation and Management of Erectile Dysfunction in the Hypertensive Patient.
Curr Cardiol Rep. 2017 Aug 24;19(9):89. doi: 10.1007/s11886-017-0889-z.
6
The epidemiology of premature ejaculation.
Transl Androl Urol. 2016 Aug;5(4):409-15. doi: 10.21037/tau.2016.05.11.
7
Interplay Between Premature Ejaculation and Erectile Dysfunction: A Systematic Review and Meta-Analysis.
J Sex Med. 2015 Dec;12(12):2291-300. doi: 10.1111/jsm.13041. Epub 2015 Nov 9.
8
Antihypertensive Drugs and Male Sexual Dysfunction: A Review of Adult Hypertension Guideline Recommendations.
J Cardiovasc Pharmacol Ther. 2016 May;21(3):233-44. doi: 10.1177/1074248415598321. Epub 2015 Oct 7.
10
Antihypertensive therapy causes erectile dysfunction.
Curr Opin Cardiol. 2015 Jul;30(4):383-90. doi: 10.1097/HCO.0000000000000189.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验